FDA Approved Drugs and User Comments: RYDAPT

User Comments:


For Systemic Mastocytosis “We have been in a single clinical trial and it has improved the quality of life by 50 % in the last 6 months , after having systemic mastocytosis (smc) for 20 years.”

harose (taken for 6 months to 1 year) May 19, 2017

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.